Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -18.88% | -2.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.88% | -2.87% | |||
| Cost of Revenue | -3.46% | -0.64% | |||
| Gross Profit | -32.20% | -4.71% | |||
| SG&A Expenses | -2.86% | -0.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -10.45% | 21.73% | |||
| Total Operating Expenses | -4.43% | -0.46% | |||
| Operating Income | -92.38% | -13.53% | |||
| Income Before Tax | -87.85% | -17.60% | |||
| Income Tax Expenses | -105.71% | -15.16% | |||
| Earnings from Continuing Operations | -82.54% | -18.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -101.87% | 90.36% | |||
| Net Income | -82.86% | -17.51% | |||
| EBIT | -92.38% | -13.53% | |||
| EBITDA | -75.74% | -10.05% | |||
| EPS Basic | -82.89% | -17.50% | |||
| Normalized Basic EPS | -89.21% | -13.59% | |||
| EPS Diluted | -82.88% | -17.51% | |||
| Normalized Diluted EPS | -89.21% | -13.66% | |||
| Average Basic Shares Outstanding | 0.13% | -0.01% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||